Richard A. Graham, SVP, RESEARCH & DEVELOPMENT at Theravance Biopharma, Inc. (TBPH), sold 2,084 shares at $10.73 ($22K) on 2022-12-01, disclosed to the SEC on 2022-12-05.
Open-market sale of $22k TBPH by SVP, RESEARCH & DEVELOPMENT. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| TBPH | SELL | 2023-09-18 | $25K | — | Filing → |
| TBPH | SELL | 2023-08-15 | $23K | — | Filing → |
| TBPH | SELL | 2023-07-18 | $23K | — | Filing → |